From Isolation to Implantation: a Concise Review of Mesenchymal Stem Cell Therapy in Bone Fracture Repair

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2014 Aug 8

PMID 25099622

Citations 45

Authors

Luke Watson

Stephen J Elliman

Cynthia M Coleman

Affiliations

Soon will be listed here.

Abstract

Compromised bone-regenerating capability following a long bone fracture is often the result of reduced host bone marrow (BM) progenitor cell numbers and efficacy. Without surgical intervention, these malunions result in mobility restrictions, deformities, and disability. The clinical application of BM-derived mesenchymal stem cells (MSCs) is a feasible, minimally invasive therapeutic option to treat non-union fractures. This review focuses on novel, newly identified cell surface markers in both the mouse and human enabling the isolation and purification of osteogenic progenitor cells as well as their direct and indirect contributions to fracture repair upon administration. Furthermore, clinical success to date is summarized with commentary on autologous versus allogeneic cell sources and the methodology of cell administration. Given our clinical success to date in combination with recent advances in the identification, isolation, and mechanism of action of MSCs, there is a significant opportunity to develop improved technologies for defining therapeutic MSCs and potential to critically inform future clinical strategies for MSC-based bone regeneration.

Citing Articles

Sustainably cultured coral scaffold supports human bone marrow mesenchymal stromal cell osteogenesis.

Gentili C, Palama M, Sexton G, Maybury S, Shanahan M, Omowunmi-Kayode Y Regen Ther. 2024; 26:366-381.

PMID: 39050552 PMC: 11267040. DOI: 10.1016/j.reth.2024.06.002.

Priming with a Combination of FGF2 and HGF Restores the Impaired Osteogenic Differentiation of Adipose-Derived Stem Cells.

Park J, Kim D, Hong H Cells. 2022; 11(13).

PMID: 35805126 PMC: 9265418. DOI: 10.3390/cells11132042.

A Review Into the Insights of the Role of Endothelial Progenitor Cells on Bone Biology.

Shi H, Zhao Z, Jiang W, Zhu P, Zhou N, Huang X Front Cell Dev Biol. 2022; 10:878697.

PMID: 35686054 PMC: 9173585. DOI: 10.3389/fcell.2022.878697.

Effects of Systemic or Local Administration of Mesenchymal Stem Cells from Patients with Osteoporosis or Osteoarthritis on Femoral Fracture Healing in a Mouse Model.

Laguna E, Perez-Nunez M, Del Real A, Menendez G, Sainz-Aja J, Lopez-Delgado L Biomolecules. 2022; 12(5).

PMID: 35625649 PMC: 9138345. DOI: 10.3390/biom12050722.

Xenotransplantation of cryopreserved human clumps of mesenchymal stem cells/extracellular matrix complexes pretreated with IFN-γ induces rat calvarial bone regeneration.

Ogawa T, Kajiya M, Horikoshi S, Yoshii H, Yoshino M, Motoike S Regen Ther. 2022; 20:117-125.

PMID: 35582709 PMC: 9065482. DOI: 10.1016/j.reth.2022.04.003.

References

Morikawa S, Mabuchi Y, Kubota Y, Nagai Y, Niibe K, Hiratsu E . Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med. 2009; 206(11):2483-96. PMC: 2768869. DOI: 10.1084/jem.20091046. View

Liebergall M, Schroeder J, Mosheiff R, Gazit Z, Yoram Z, Rasooly L . Stem cell-based therapy for prevention of delayed fracture union: a randomized and prospective preliminary study. Mol Ther. 2013; 21(8):1631-8. PMC: 3739419. DOI: 10.1038/mt.2013.109. View

Jones E, McGonagle D . Human bone marrow mesenchymal stem cells in vivo. Rheumatology (Oxford). 2007; 47(2):126-31. DOI: 10.1093/rheumatology/kem206. View

Myers T, Yan Y, Granero-Molto F, Weis J, Longobardi L, Li T . Systemically delivered insulin-like growth factor-I enhances mesenchymal stem cell-dependent fracture healing. Growth Factors. 2012; 30(4):230-41. PMC: 3752908. DOI: 10.3109/08977194.2012.683188. View

Mendez-Ferrer S, Michurina T, Ferraro F, Mazloom A, MacArthur B, Lira S . Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010; 466(7308):829-34. PMC: 3146551. DOI: 10.1038/nature09262. View

Gerstenfeld L, Cho T, Kon T, Aizawa T, Tsay A, Fitch J . Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. J Bone Miner Res. 2003; 18(9):1584-92. DOI: 10.1359/jbmr.2003.18.9.1584. View

Tortelli F, Tasso R, Loiacono F, Cancedda R . The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. Biomaterials. 2009; 31(2):242-9. DOI: 10.1016/j.biomaterials.2009.09.038. View

Hernigou P, Poignard A, Beaujean F, Rouard H . Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am. 2005; 87(7):1430-7. DOI: 10.2106/JBJS.D.02215. View

Sacchetti B, Funari A, Michienzi S, Cesare S, Piersanti S, Saggio I . Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell. 2007; 131(2):324-36. DOI: 10.1016/j.cell.2007.08.025. View

10.

Cipitria A, Reichert J, Epari D, Saifzadeh S, Berner A, Schell H . Polycaprolactone scaffold and reduced rhBMP-7 dose for the regeneration of critical-sized defects in sheep tibiae. Biomaterials. 2013; 34(38):9960-8. DOI: 10.1016/j.biomaterials.2013.09.011. View

11.

Mathieu M, Rigutto S, Ingels A, Spruyt D, Stricwant N, Kharroubi I . Decreased pool of mesenchymal stem cells is associated with altered chemokines serum levels in atrophic nonunion fractures. Bone. 2013; 53(2):391-8. DOI: 10.1016/j.bone.2013.01.005. View

12.

Taguchi K, Ogawa R, Migita M, Hanawa H, Ito H, Orimo H . The role of bone marrow-derived cells in bone fracture repair in a green fluorescent protein chimeric mouse model. Biochem Biophys Res Commun. 2005; 331(1):31-6. DOI: 10.1016/j.bbrc.2005.03.119. View

13.

Nakamura Y, Arai F, Iwasaki H, Hosokawa K, Kobayashi I, Gomei Y . Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells. Blood. 2010; 116(9):1422-32. DOI: 10.1182/blood-2009-08-239194. View

14.

Marcacci M, Kon E, Moukhachev V, Lavroukov A, Kutepov S, Quarto R . Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng. 2007; 13(5):947-55. DOI: 10.1089/ten.2006.0271. View

15.

Pereira R, Halford K, OHara M, Leeper D, Sokolov B, Pollard M . Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A. 1995; 92(11):4857-61. PMC: 41806. DOI: 10.1073/pnas.92.11.4857. View

16.

von Bahr L, Batsis I, Moll G, Hagg M, Szakos A, Sundberg B . Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. Stem Cells. 2012; 30(7):1575-8. DOI: 10.1002/stem.1118. View

17.

Rundle C, Wang H, Yu H, Chadwick R, Davis E, Wergedal J . Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair. Bone. 2005; 38(4):521-9. DOI: 10.1016/j.bone.2005.09.015. View

18.

Scotti C, Tonnarelli B, Papadimitropoulos A, Scherberich A, Schaeren S, Schauerte A . Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering. Proc Natl Acad Sci U S A. 2010; 107(16):7251-6. PMC: 2867676. DOI: 10.1073/pnas.1000302107. View

19.

Burastero G, Scarfi S, Ferraris C, Fresia C, Sessarego N, Fruscione F . The association of human mesenchymal stem cells with BMP-7 improves bone regeneration of critical-size segmental bone defects in athymic rats. Bone. 2010; 47(1):117-26. DOI: 10.1016/j.bone.2010.03.023. View

20.

Bruder S, Kraus K, Goldberg V, Kadiyala S . The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am. 1998; 80(7):985-96. DOI: 10.2106/00004623-199807000-00007. View